Reed's Inc

REED

Market cap $44.2M

NORWALK, Conn., April 24, 2026 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE American: REED) (“Reed's” or the “Company”), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the appointment of Damian Warshall as Chief Operating Officer, effective April 27, 2026.

Reed's, Inc. (REED) Q4 2025 Earnings Call Transcript

Profitable Growth Initiatives Lead to Sequential Quarterly Improvement  Neal Cohane Appointed Interim Chief Executive Officer NORWALK, Conn., March 24, 2026 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE American: REED) (“Reed's” or the “Company”), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced financial results for the three months and 12 months ended December 31, 2025.

NORWALK, Conn., March 11, 2026 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE American: REED) (“Reed's” or the “Company”), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, will host a conference call on Wednesday, March 25, 2026, at 8:30 a.m. Eastern time to discuss its financial results for the three and twelve months ended December 31, 2025. The Company's results will be reported in a press release prior to the call.

NORWALK, Conn., Dec. 29, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE American: REED) (“Reed's” or the “Company”), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the appointment of Neal Cohane as Chief Operating Officer, effective January 5, 2026.

NORWALK, Conn., Dec. 08, 2025 (GLOBE NEWSWIRE) -- Reed's, Inc. (NYSE American: REED) (“Reed's” or the “Company”), owner of the nation's leading portfolio of handcrafted, natural ginger beverages, today announced the closing of its previously announced underwritten public offering of 2,500,000 shares of its common stock and warrants to purchase 2,500,000 shares of common stock (collectively, the “Securities”). Each share of common stock and accompanying warrant to purchase one share of common stock were sold together at a combined public offering price of $4.00. The warrants have an exercise price of $4.50 per share, are exercisable immediately and will expire five years from the issuance date. In addition, Reed's granted the underwriters a 45-day option to purchase up to an additional 375,000 shares of common stock and/or 375,000 warrants at their respective public offering prices, less underwriting discounts and commissions.

The US IPO market entered the final stretch of the year with a few small listings, a wave of SPACs, and three notable deal launches on the calendar for the week ahead. With markets recovering from a recent sell-off in growth stocks, we expect several more launches from the pipeline to tee up listings for mid-December, including a potential mega IPO from medical supplies giant Medline. Several lock-ups are expiring in the week ahead, including four from companies that raised at least $50 million.